Aarti Pharmalabs Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 4,850.6 million compared to INR 4,603 million a year ago. Revenue was INR 4,858 million compared to INR 4,628.2 million a year ago. Net income was INR 428.7 million compared to INR 488.7 million a year ago. Basic earnings per share from continuing operations was INR 4.73 compared to INR 5.39 a year ago. Diluted earnings per share from continuing operations was INR 4.73 compared to INR 5.39 a year ago.
For the full year, sales was INR 19,452.3 million compared to INR 11,999.4 million a year ago. Revenue was INR 19,475.5 million compared to INR 12,024.6 million a year ago. Net income was INR 1,934.9 million compared to INR 1,222.5 million a year ago. Basic earnings per share from continuing operations was INR 21.35 compared to INR 13.49 a year ago. Diluted earnings per share from continuing operations was INR 21.35 compared to INR 13.49 a year ago.